Hospital de San Jose Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2010
NCT01746641
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Hospital de San Jose

Active Ingredients

Drugs in Phase 4 Trials (2)

propofol (diprivan) (1 trial)

remifentanil (ultiva) (2 trials)

Drugs in Phase 3 Trials (1)

colchicine (colbenemid) (1 trial)

Drugs in Phase 2 Trials (1)

umbilical cord mesenchymal stem cells (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronavirus Infections (Phase 3)

Severe Acute Respiratory Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 4